I think that being told this at sixteen would be incredibly hard.
I understand where you are coming from but should a 16-year-old girl who develops lupus be told there is a cure as long as she goes to psychotherapy and exercises?
Welcome to Phoenix Rising!
Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.
To become a member, simply click the Register button at the top right.
I think that being told this at sixteen would be incredibly hard.
I think this is very much the case. Self interest can do what conspiracy can fail to do. It can corrupt, distort, and derail, and all with no conspiratorial paper trail. From the outside it might appear conspiratorial, but its really just people, and organizations of people, just doing their own thing to the detriment of some other group.In the case of ME/CFS, I think we've seen this situation where there are various self-interested groups all pulling in the same direction, but all for their own reasons, and the resulting tide has been moving in a direction that's not in the interests of patients.
Further discrediting the so-called Type A Behavior Pattern (TABP), a study from 2012 – based on searching the Legacy Tobacco Documents Library – suggests the phenomenon of initially promising results followed by negative findings to be partly explained by the tobacco industry’s involvement in TABP research to undermine the scientific evidence on smoking and health. The industry’s interest in TABP lasted at least four decades until the late 1990s, involving substantial funding to key researchers encouraged to prove smoking to simply correlate with a personality type prone to coronary heart disease (CHD) and cancer.[7] Hence, until the early 1980s, the industry’s strategy consisted of suggesting the risks of smoking to be caused by psychological characteristics of individual smokers rather than tobacco products by deeming the causes of cancer to be multifactorial with stress as a key contributing factor.[8][9][10] Philip Morris (today Altria) and RJ Reynolds helped generate substantial evidence to support these claims by funding workshops and research aiming to educate about and alter TABP to reduce risks of CHD and cancer. Moreover, Philip Morris primarily funded the Meyer Friedman Institute, e.g. conducting the “crown-jewel” trial on the effectiveness of reducing TABP whose expected findings could discredit studies associating smoking with CHD and cancer but failing to control for Type A behaviour.[7]
In 1994, Friedman wrote to the US Occupational Safety and Health Administration criticising restrictions on indoor smoking to reduce CHD, claiming the evidence remained unreliable since it did not account for the significant confounder of Type A behaviour, notwithstanding the fact that by then, TABP had proven to be significant in only three of twelve studies. Though apparently unpaid for, this letter was approved by and blind-copied to Philip Morris, and Friedman (falsely) claimed to receive funding largely from the National Heart, Lung and Blood Institute.[11] When TABP finally became untenable, Philip Morris supported research on its hostility component,[12] allowing Vice President Jetson Lincoln to explain passive smoking lethality by the stress exerted on a non-smoking spouse through media claiming the smoking spouse to be slowly killing themselves.[13] When examining the most recent review on TABP and CHD in this light, the close relationship to the tobacco industry becomes evident: of thirteen etiologic studies in the review, only four reported positive findings,[14] three of which had a direct or indirect link to the industry. Also on the whole most TABP studies had no relationship to the tobacco lobby but the majority of those with positive findings did.[7] Furthermore, TABP was used as a litigation defence, similar to psychosocial stress.[15] Hence, Petticrew et al. proved the tobacco industry to have substantially helped generate the scientific controversy on TABP, contributing to the (in lay circles) enduring popularity and prejudice for Type A personality even though it has been scientifically disproven.[7]
One reason why the situation for ME/CFS may change faster than we expect, is because the rate of change for scientific technology and knowledge is exponential, just like all other technology. The rate of scientific and medical progress is faster now than any time in history. Athough research dollars aren't being invested in ME/CFS specifically, money is being spent on loads of other related areas of research that may potentially have a direct impact on our illness.
Money is being invested in other areas of immunology and autoimmune illness where discoveries are being made all the time e.g. with regard to how cells function; Lab technology is transforming at a fast pace - we're always hearing of new technology being installed in labs; Immune modulators, autoimmune drugs and antivirals are continuously being developed; We're gaining more insight into autoimmunity and types of autoantibodies all the time; and insight into other diseases e.g. involving the mitochondrial and brain.
Also, other chance discoveries such as Fluge and Mella's may come about. And once we have one pharmacological treatment under our belt, then I think research should pick up pace, and funding become easier. More researchers will undoubtedly get involved. Hopefully the IOM and P2P reports will change things drastically too, but that remains just a hope at the moment.
Dr Lipkin and Dr Hornig are working on finding biomarker, and treatment, and they're even looking for a cause. They're just beginning to look at NK cells using new technology, and they seem to be doing a vast range of investigations. So something might come from their work. But there are quite a number of other high profile researchers who have recently entered the field. And people like Nancy Klimas, and partners, are doing an incredibly large amount of research. The CDC are even doing biomedical work now in relation to their multi-site study.
Anyway, I just thought I'd list some reasons to be optimistic, for the medium term.
Charles and Jonathan report good things from their meeting, and although we've been a bit sceptical, I've noticed a definite shift in attitudes the UK. I think the patient community is being heard. The message about the PACE trial, and related research, has definitely been heard. There were positive vibes coming from NICE when Charles has interacted with them. I think a shift has begun that we can build upon.
I get the distinct impression that the ground has quietly but firmly shifted in the last 3-4 years, and we are only now starting to see the practical consequences coming to the fore.Charles and Jonathan report good things from their meeting, and although we've been a bit sceptical, I've noticed a definite shift in attitudes the UK. I think the patient community is being heard. The message about the PACE trial, and related research, has definitely been heard. There were positive vibes coming from NICE when Charles has interacted with them. I think a shift has begun that we can build upon.
I like him best!
Is it just me or does it seem that lately, these sort of things never turn out half as bad as we expect them to? A sign of the times maybe? Certainly a sign of some people's waning influence.
I know I am guilty of over generalising from experience of the Bath paediatric ME service where they basically run a graded activity program. They too tend not to mention exercise. They promise 97% success but remove patients that they feel aren't following their programme (i.e. aren't getting better) and I was told that 'my child couldn't have CFS/ME since she had been ill for too long. She had CFS/ME (since their original diagnosis must be right) and they had cured that with their activity management program (consisting of a leaflet and an occasional phone call) despite no symptom change. But I was then told my child who was pretty much bed bound at the time must have been suffering from a dissociative disorder from the stress of being ill. I must say I wasn't surprised as I had heard that the clinic took that approach.
I think there's an institutionalized attitude which would remain. Even if some new people come on board, the old experienced "experts" still around are going to be seen as an authority. And then their nasty attitude just gets passed on to the new clinicians, unless they're already very well-informed regarding biological research.
I really think they need to go. A fresh start gets a complete break from the old attitudes.
There wasn't any real discussion on diet and dietary intervention. There was a short discussion on the role of trace elements, vitamins, supplements (magnesium in particular) following on from two questions at the end - one of which came from someone who I think was some form of nutritional therapist who wanted to see research into the efficacy of these type of interventions.
I think there probably is room for optimism, but we've seen so much dishonesty that we're cynical and we've learned not to take things at face value.
Hopefully there is progress, but please don't accept the use of language at face value. We're all far too familiar with how clever language can persuade the government and health authorities that ME patients just need a pat on the head.
There was a sense at the meeting that everyone was very aware that they needed to justify what they were saying - a more self-critical atmosphere than often at medical meetings. At least up until now that must reflect patient pressure.
I do not know if there is any stipulation on which service ME/CFS comes under. The clinicians I know are in departments of immunology, medicine and paediatrics and that seems fine to me. I don't think community services should be separate from hospital services. I think we should go back to the days when home visits were done by professionals with special expertise based in hospital units. One possibly positive aspect of the current 'choice' obsession is that if an immunologist set up an ME/CFS clinic and managed to provide good care without having to employ a psychologist then they might draw business from a department down the road. I am not directly enough involved with care to say anything very sensible though.
I also agree that the cultural shift will come about as soon as pharmacological treatments are discovered.
I know of patients who had home help services supplied, but I am not sure who did that. However it turns out that the help consists of helping you to do more. CBT/GET in disguise. This has led patients to become afraid of the "help" they are offered.
I understand your concern about this. But the fact that there is as yet no proven treatment that the NHS (assuming you're in the UK, given that you're a mum and not a mom!) can offer doesn't mean that there's no helpful treatment that you might try to find on your own (the position that most of us here are in), or that some spontaneous improvement might not gradually occur (especially at 16 rather than when older).
As a patient, it's important not to be lied to, especially when the treatment that people are lying to you about (GET) can be extremely harmful.
There is only one way forward and that is for the relevant researchers to sit down yet again and write applications yet again and hope that this time something will hit the right button. They will do that and from time to time they will succeed.
Yes, i agree that subgroups will probably prove to be important. But subgroups can be defined by the patients who respond to any treatments that are tested. Fluge and Mella are uncovering subgroups; The next step for them is to see if they can define which of their patients respond to rituximab, and then they can provide rituximab only to the specific patients who they know will respond. So, subgroups can be defined by treatments.Sadly I have my doubts that we will get good pharmacological treatments until its got to the point in which they can study using subgroups... and right now the IOM couldn't even come up with subgroups. I think unless they stumble across a phama answer for it, I think treatment may be a long way away.